Research and Markets: Pancreatic Cancer Drug Pipeline Update 2015: 291 companies plus partners developing 347 drugs targeting pancreatic cancer in development

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/2ww7hq/pancreatic_cancer) has announced the addition of the "Pancreatic Cancer Drug Pipeline Update 2015" report to their offering.

There are today 291 companies plus partners developing 347 drugs targeting pancreatic cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 128 drugs. Pancreatic Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 312 different targets.

All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 299 out of the 304 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information.

All drugs targets are further categorized on in the software application by 70 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.

Pipeline Breakdown According to Number of Drugs

  • Marketed - 14
  • Registered - 1
  • Pre-registration - 1
  • Phase III - 26
  • Phase II - 127
  • Phase I - 91
  • Preclinical - 82
  • No Data - 5
  • Suspended - 1
  • Ceased - 128

For more information visit http://www.researchandmarkets.com/research/2ww7hq/pancreatic_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology